The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy
Open accessAbstract
Background— Myocardial late gadolinium enhancement (LGE) on contrast-enhanced magnetic resonance imaging (CE-MRI) of patients with hypertrophic cardiomyopathy (HCM) has been suggested to represent intramyocardial fibrosis and, as such, an adverse prognostic risk factor. We evaluated the characteristics of LGE on CE-MRI and explored whether LGE among patients with HCM was associated with genetic testing, severe symptoms, ventricular arrhythmias, or sudden cardiac death (SCD). Methods and Results— Four hundred twenty-four patients with HCM (age=55±16 years [range 2 to 90], 41% females), without a history of septal ablation/myectomy, underwent CE-MRI (GE 1.5 Tesla). We evaluated the relation between LGE and HCM genes status, severity of symptoms, and the degree of ventricular ectopy on Holter ECG. Subsequent SCD and appropriate implanted cardioverter defibrillator (ICD) therapies were recorded during a mean follow-up of 43±14 months (range 16 to 94). Two hundred thirty-nine patients (56%) had LGE on CE-MRI, ranging from 0.4% to 65% of the left ventricle. Gene-positive patients were more likely to have LGE ( P <0.001). The frequencies of New York Heart Association class ≥3 dyspnea and angina class ≥3 were similar in patients with and without LGE (125 of 239 [52%] versus 94 of 185 [51%] and 24 of 239 [10%] versus 18 of 185 [10%], respectively, P =NS). LGE-positive patients were more likely to have episodes of nonsustained ventricular tachycardia (34 of 126 [27%] versus 8 of 94 [8.5%], P <0.001), had more episodes of nonsustained ventricular tachycardia per patient (4.5±12 versus 1.1±0.3, P =0.04), and had higher frequency of ventricular extrasystoles/24 hours (700±2080 versus 103±460, P =0.003). During follow-up, SCD occurred in 4 patients, and additional 4 patients received appropriate ICD discharges. All 8 patients were LGE positive (event rate of 0.94%/y, P =0.01 versus LGE negative). Two additional heart failure-related deaths were recorded among LGE-positive patients. Univariate associates of SCD or appropriate ICD discharge were positive LGE ( P =0.002) and presence of nonsustained ventricular tachycardia ( P =0.04). The association of LGE with events remained significant after controlling for other risk factors. Conclusions— In patients with HCM, presence of LGE on CE-MRI was common and more prevalent among gene-positive patients. LGE was not associated with severe symptoms. However, LGE was strongly associated with surrogates of arrhythmia and remained a significant associate of subsequent SCD and/or ICD discharge after controlling for other variables. If replicated, LGE may be considered an important risk factor for sudden death in patients with HCM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kim, R. J., Wu, E., Rafael, A., Chen, E.-L., Parker, M. A., Simonetti, O., Klocke, F. J., Bonow, R. O., & Judd, R. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432003 · Cited by 3,306
Hypertrophic Cardiomyopathy: A Systematic Review
Maron, B. J. (2002) · JAMA · doi:10.1001/jama.287.10.1308 · Cited by 2,224 · cited 2×
“The following baseline characteristics were recorded: (1) hypertension (blood pressure of 140/90 or treatment with antihypertensive medications); (2) diabetes mellitus (patient history and/or treatment with insulin or oral hypoglycemic agents); (3) family history of HCM in first-degree relatives; (4) coronary artery d…”
BackgroundMethodHypertrophic Cardiomyopathy: The Therapeutic Role of Calcium Antagonists
(1982) · Springer eBooks · doi:10.1007/978-3-642-68282-7 · Cited by 1,756
An Improved MR Imaging Technique for the Visualization of Myocardial Infarction
Simonetti, O. P., Kim, R. J., Fieno, D. S., Hillenbrand, H. B., Wu, E., Bundy, J. M., Finn, J. P., & Judd, R. M. (2001) · Radiology · doi:10.1148/radiology.218.1.r01ja50215 · Cited by 1,358
Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy
Assomull, R. G., Prasad, S. K., Lyne, J., Smith, G., Burman, E. D., Khan, M., Sheppard, M. N., Poole-Wilson, P. A., & Pennell, D. J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.049 · Cited by 1,164
The Management of Hypertrophic Cardiomyopathy
Spirito, P., Seidman, C. E., McKenna, W. J., & Maron, B. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703133361107 · Cited by 1,007
Sudden death in hypertrophic cardiomyopathy: identification of high risk patients
Elliott, P. M., Poloniecki, J., Dickie, S., Sharma, S., Monserrat, L., Varnava, A., Mahon, N. G., & McKenna, W. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01003-2 · Cited by 978
Maron, B. J., Bonow, R. O., Cannon, R. O., Leon, M. B., & Epstein, S. E. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703263161305 · Cited by 896
Maron, B. J., Spirito, P., Shen, W.-K., Haas, T. S., Formisano, F., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Lawrenz, T., et al. (2007) · JAMA · doi:10.1001/jama.298.4.405 · Cited by 804
Kwong, R. Y., Chan, A. K., Brown, K. A., Chan, C. W., Reynolds, H. G., Tsang, S., & Davis, R. B. (2006) · Circulation · doi:10.1161/circulationaha.105.570648 · Cited by 753
Yan, A. T., Shayne, A. J., Brown, K. A., Gupta, S. N., Chan, C. W., Luu, T. M., Di Carli, M. F., Reynolds, H. G., Stevenson, W. G., & Kwong, R. Y. (2006) · Circulation · doi:10.1161/circulationaha.106.613414 · Cited by 750
Adabag, A. S., Maron, B. J., Appelbaum, E., Harrigan, C. J., Buros, J. L., Gibson, C. M., Lesser, J. R., Hanna, C. A., Udelson, J. E., Manning, W. J., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.11.071 · Cited by 662
Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy
Choudhury, L., Mahrholdt, H., Wagner, A., Choi, K. M., Elliott, M. D., Klocke, F. J., Bonow, R. O., Judd, R. M., & Kim, R. J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02602-5 · Cited by 627
Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy
Monserrat, L., Elliott, P. M., Gimeno, J. R., Sharma, S., Penas-Lado, M., & McKenna, W. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00827-1 · Cited by 541
Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease
Varnava, A. M. (2000) · Heart · doi:10.1136/heart.84.5.476 · Cited by 441
Basso, C. (2000) · Human Pathology · doi:10.1053/hupa.2000.16659 · Cited by 418
Shirani, J., Pick, R., Roberts, W. C., & Maron, B. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00492-1 · Cited by 408
Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
Sorajja, P., Valeti, U., Nishimura, R. A., Ommen, S. R., Rihal, C. S., Gersh, B. J., Hodge, D. O., Schaff, H. V., & Holmes, D. R. (2008) · Circulation · doi:10.1161/circulationaha.107.738740 · Cited by 310
Self-citationClinical Profile and Significance of Delayed Enhancement in Hypertrophic Cardiomyopathy
Maron, M. S., Appelbaum, E., Harrigan, C. J., Buros, J., Gibson, C. M., Hanna, C., Lesser, J. R., Udelson, J. E., Manning, W. J., & Maron, B. J. (2008) · Circulation: Heart Failure · doi:10.1161/circheartfailure.108.768119 · Cited by 294
Natural History of Hypertrophic Cardiomyopathy: A Population-Based Study, 1976 Through 1990
Cannan, C. R., Reeder, G. S., Bailey, K. R., Melton, L. J., & Gersh, B. J. (1995) · Circulation · doi:10.1161/01.cir.92.9.2488 · Cited by 264
Self-citationAutore, C., Bernabò, P., Barillà, C. S., Bruzzi, P., & Spirito, P. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.12.067 · Cited by 260
Binder, J., Ommen, S. R., Gersh, B. J., Van Driest, S. L., Tajik, A. J., Nishimura, R. A., & Ackerman, M. J. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.4.459 · Cited by 236
Self-citationValeti, U. S., Nishimura, R. A., Holmes, D. R., Araoz, P. A., Glockner, J. F., Breen, J. F., Ommen, S. R., Gersh, B. J., Tajik, A. J., Rihal, C. S., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.055 · Cited by 233
Self-citationKubo, T., Gimeno, J. R., Bahl, A., Steffensen, U., Steffensen, M., Osman, E., Thaman, R., Mogensen, J., Elliott, P. M., Doi, Y., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.061 · Cited by 219
McLeod, C. J., Ommen, S. R., Ackerman, M. J., Weivoda, P. L., Shen, W. K., Dearani, J. A., Schaff, H. V., Tajik, A. J., & Gersh, B. J. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm117 · Cited by 203
Self-citationDearani, J. A., Ommen, S. R., Gersh, B. J., Schaff, H. V., & Danielson, G. K. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0965 · Cited by 159
Self-citationLin, G., Nishimura, R. A., Gersh, B. J., Phil, D., Ommen, S. R., Ackerman, M. J., & Brady, P. A. (2009) · Heart · doi:10.1136/hrt.2008.150656 · Cited by 158
Self-citationMaron, B. J., Maron, M. S., Lesser, J. R., Hauser, R. G., Haas, T. S., Harrigan, C. J., Appelbaum, E. A., Main, M. L., & Roberts, W. C. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.09.101 · Cited by 81
Woo, A., Monakier, D., Harris, L., Hill, A., Shah, P., Wigle, E. D., Rakowski, H., Rozenblyum, E., & Cameron, D. (2007) · Heart · doi:10.1136/hrt.2006.090290 · Cited by 77
Soler, R., guez, E. R., Monserrat, L., ndez, C. M., & nez, C. M. (2006) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-200605000-00011 · Cited by 55
Matoh, F., Satoh, H., Shiraki, K., Saitoh, T., Urushida, T., Katoh, H., Takehara, Y., Sakahara, H., & Hayashi, H. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.02.001 · Cited by 49
Motoyasu, M., Kurita, T., Onishi, K., Uemura, S., Tanigawa, T., 沖中, 務., Takeda, K., Nakano, T., Ito, M., & Sakuma, H. (2008) · Circulation Journal · doi:10.1253/circj.72.378 · Cited by 49
The emerging role of MRI in the diagnosis and management of cardiomyopathies
Rochitte, C. E., Tassi, E. M., & Shiozaki, A. A. (2006) · Current Cardiology Reports · doi:10.1007/s11886-006-0010-5 · Cited by 41
Relationship between sex, shape, and substrate in hypertrophic cardiomyopathy
Bos, J. M., Theis, J. L., Tajik, A. J., Gersh, B. J., Ommen, S. R., & Ackerman, M. J. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.01.005 · Cited by 36
Self-citationMaron, M. S., Zenovich, A. G., Casey, S. A., Link, M. S., Udelson, J. E., Aeppli, D. M., & Maron, B. J. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.01.077 · Cited by 34
Hypertrophic Cardiomyopathy, Sudden Death, and Implantable Cardiac Defibrillators
Nishimura, R. A., & Ommen, S. R. (2007) · JAMA · doi:10.1001/jama.298.4.452 · Cited by 31
Self-citationRisk stratification of sudden cardiac death in hypertrophic cardiomyopathy
Miller, M. A., Gomes, J. A., & Fuster, V. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1057 · Cited by 24
Cited by
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,104
Self-citationAl-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.054 · Cited by 1,854
Self-citation2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.011 · Cited by 1,276
Self-citationOmmen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.044 · Cited by 994
Self-citation
Metadata
- Authors
- Rubinshtein, R., Glockner, J. F., Ommen, S. R., Araoz, P. A., Ackerman, M. J., Sorajja, P., Bos, J. M., Tajik, A. J., Valeti, U. S., Nishimura, R. A., & Gersh, B. J.
- Venue
- Circulation: Heart Failure
- Published
- 2010-01
- Volume
- 3
- Issue
- 1
- Pages
- 51-58
- ISSN
- 1941-3289 (ISSN-L)
- 1941-3297
- OpenAlex
- W2127823551
- Cited by
- 418
- References
- 37
- FWCI
- 18.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.